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Background
Cardiac homeostasis is a complex phenomenon, which
is maintained by the interplay of factors that up and
down regulate blood pressure. Natriuretic peptides
(NPs), which cause vasodilation and increased water-
electrolyte excretion, are among the most vital hormo-
nal controls of blood pressure. NPs elicit their function
by binding to membrane bound guanylyl cyclase recep-
tor. Three mammalian NPs are known, namely ANP,
BNP and CNP, which are structurally similar with a 17
residue ring and a short (5-6 residues) C-terminal tail.
Results
Here, we describe the characterization of a novel NP
from krait venom (KNP). In contrast to mammalian
NPs, KNP has an extensively long 38 residue C-terminal
tail, which has propensity to form a-helix, unlike other
elapid NPs. The ex-vivo organ bath studies showed that
the ability of KNP to relax the pre-contracted aortic
strip was weaker than ANP, and it does so via a differ-
ent mechanism. It arbitrates vasodilation via endothe-
lium-dependent pathways in contrast to ANP which
mediates via endothelium-independent mechanisms.
Putative helical segment showed an equipotent vasore-
laxation in an endothelium-dependent manner, while
only the ring of KNP showed similar vasorelaxation as
ANP in an endothelium-independent manner. Deletion
of the C-terminal helical segment abrogates KNP’s activ-
ity suggesting its definitive role in vasorelaxation.
Further with different inhibitors, we have delineated the
necessity for nitric oxide, prostacyclin and endothelium
derived hyperpolarization factor (EDHF) for KNP
mediated vasodilation.
Conclusion
We have established that KNP mediates vasodilation
by a unique mechanism that can be attributed to its
C-terminal tail.
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